{
    "2020-09-23": [
        [
            {
                "time": "2020-01-01",
                "original_text": "CRO&CDMO投研体系之数据跟踪(系列四)：2020H1回顾与前瞻 疫情背景下中国企业竞争优势凸显",
                "features": {
                    "keywords": [
                        "疫情",
                        "竞争优势",
                        "CRO",
                        "CDMO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "泰格医药(03347.HK)拟参与认购嘉和生物首次公开发行股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "嘉和生物",
                        "IPO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-16",
                "original_text": "泰格医药(03347.HK)拟参与投资泰誉三期医疗器械基金",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "医疗器械",
                        "基金"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-20",
                "original_text": "医药行业周报：医保目录调整逐步进行 冠状动脉支架首批纳入器械国采",
                "features": {
                    "keywords": [
                        "医保目录",
                        "冠状动脉支架",
                        "器械国采"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-01",
                "original_text": "泰格医药(300347.SZ)拟2200万美元作为基石投资者参与认购嘉和生物(06998)股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "嘉和生物",
                        "IPO",
                        "基石投资者"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-02",
                "original_text": "泰格医药：子公司拟作为基石投资者认购嘉和生物港股IPO股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "嘉和生物",
                        "港股IPO",
                        "基石投资者"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-03",
                "original_text": "泰格医药：全资子公司拟以基石投资者身份参与嘉和生物香港首次公开发行",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "嘉和生物",
                        "香港IPO",
                        "基石投资者"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-04",
                "original_text": "泰格医药(300347.SZ)：拟出资2.4亿元参投泰誉三期医疗器械基金",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "医疗器械",
                        "基金"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-05",
                "original_text": "泰格医药(300347.SZ)：子公司拟以基石投资者身份认购嘉和生物H股IPO股票",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "嘉和生物",
                        "H股IPO",
                        "基石投资者"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-06",
                "original_text": "早间公告：泰格医药子公司拟参与嘉和生物港股IPO；中航飞机重组方案出炉",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "嘉和生物",
                        "港股IPO",
                        "中航飞机",
                        "重组"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "航空"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-07",
                "original_text": "国家级混改基金有望近期成立",
                "features": {
                    "keywords": [
                        "混改基金",
                        "国家级"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-08",
                "original_text": "医药生物行业日报：估值步入合理区间 关注超跌个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "估值",
                        "超跌个股"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}